The results suggest that the TGF-β and Hif-1α pathways may play synergetic roles in myocardial fibrosis, and the cardiac protection by valsartan after MI was through inhibiting both TGF-β and Hif-1α. The gene discussed is TGFB1; the disease is myocardial infarction.